1st Quarter - Report

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

Firm
Client
Income
—
Expenses
$200,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Agriculture, Rural Development, Food and Drug Administration, and related Agencies Appropriations seeking Food and Drug Administration funding. Discussion with the House on opioid addiction.

LobbyistCovered position, as disclosed
JOSEPH M HILL —
JILLANNE SCHULTE —
CHRISTOPHER J TOPOLESKI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

Communication with Center for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare Program, annual payment updates, and PBM transparency. Support for H.R. 592/S. 109, legislation that would amend title 18 of the Social Security Act to provide for coverage of pharmacist services under the Medicare Program. Discussion with House and Senate about increased prescription drug pricing. Communication on Direct and Indirect Remuneration fees (DIR) under Medicare Part D. Support for H.R. 4392, nullfying a rule finalized by the Centers for Medicare & Medicaid Services that modifies payment under Medicare for certain drugs purchased through the 340B discount program.

LobbyistCovered position, as disclosed
JOSEPH M HILL —
JILLANNE SCHULTE —
CHRISTOPHER J TOPOLESKI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 4392 (115th), S. 109 (115th), H.R. 592 (115th)

Pharmacy PHA

Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, implementation of the Drug Quality and Security Act. Communication with Congress on compounding. Letter to Senate leadership regarding H.R. 1628, American Health Care Act of 2017. Testified to Senate on 340B Drug Discount Program. Communicated with House and Senate offices on drug shortages.

LobbyistCovered position, as disclosed
JOSEPH M HILL —
JILLANNE SCHULTE —
CHRISTOPHER J TOPOLESKI —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 1628 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.